ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)

This global patient registry is being conducted to characterize the natural history and real-world clinical management of patients with AHP, and to further characterize the real-world safety and effectiveness of givosiran and other approved AHP therapies.

NCT Number	NCT04883905
Lead Sponsor	Alnylam Pharmaceuticals
Conditions	Acute Hepatic Porphyria
Enrollment	150 participants
Start Date	2021-04-26
Primary Completion	2027-04-01 (estimated)
Study Completion	2027-04-01 (estimated)
Updated on ClinicalTrials.gov	2026-04-27